プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Scientific W.に依頼

India

Scientist with a passion for scientific writing

プロフィール概要

During my research, I have gained experience in immunology, drug screening, molecular biology, immunological, proteomics, protein purification, and biochemical studies. I have experience in the research industry for the last 12 years, in which I have worked under various roles. It included not only basic research but also writing big grants. Just for your reference, I wish to mention that I have written and authored more than 30 international journals of good impact factor and repute. I have also authored one book chapter in Nuts and Seeds in Health and Disease Prevention, an Elsevier publication and other in springer nature. I have been actively writing projects grants for abroad and India and have got two projects sanctioned as Principal Investigator I work as a freelance scientific writer for manuscripts, review articles and book chapters along with editing and submitting them to the specific journal. Along with this, I have expertise in making scientific presentations, blogs etc.

専門分野

• ★ Biotechnology & Bioengineering
• ☆ Natural Product Chemistry
• ☆ Animal Communications
• ☆ Immunoassay
• ☆ Drug Development
• ☆ Vaccine Development
• ☆ Allergy & Clinical Immunology
• ☆ Infectious Disease
• ☆ Cancer Research

サービス

• Writing

Writing Technical Writing

職務経験

YOUNG SCIENTIST

All India Institute of Medical sciences

5月 2014 - 現在

学歴

POST-DOCTORAL

All India Institute of Medical Sciences

5月 2014 - 現在

PhD

Central Drug Research Institute

4月 2008 - 4月 2012

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

(2019). Role of cytokines in combinatorial immunotherapeutics of non‐small cell lung cancer through systems perspective . Cancer Medicine.

(2019). Prophylactic interferon-γ and interleukin-17 facilitate parasite clearance in experimental visceral leishmaniasis . Tropical parasitology.

(2018). Adjunct Therapy of rIFN-g and rIL-17A along with Sub-optimal Dose of Amphotericin-B effectively Control the Leishmania donovani Parasitic Growth in Infected Mice . Journal of Pure and Applied Microbiology.

(2018). Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate .

(2018). T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load . Clinical & Experimental Immunology.

(2015). Proteomic analyses of membrane enriched proteins of Leishmania donovani Indian clinical isolate by mass spectrometry .

(2015). Immunostimulatory potential and proteome profiling ofLeishmania donovanisoluble exogenous antigens . Parasite Immunology.

(2014). Coating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy againstLeishmaniain hamsters by inducing Th1-type immune responses . British Journal of Pharmacology.

(2014). Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance .

(2014). Characterization of the Proliferating Cell Nuclear Antigen of Leishmania donovani Clinical Isolates and Its Association with Antimony Resistance .

(2014). Fishery Resources in the Trawl Bycatches of Cuddalore and Parangipettai, Southeast Coast of India . Journal of Marine Biology & Oceanography.

(2013). Unresponsiveness of Mycobacterium w vaccine in managing acute and chronic Leishmania donovani infections in mouse and hamster .

(2013). Amplified fragment length polymorphism: an adept technique for genome mapping, genetic differentiation, and intraspecific variation in protozoan parasites .

(2012). Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis .

(2012). Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters .

(2012). Leishmania donovani: Immunostimulatory Cellular Responses of Membrane and Soluble Protein Fractions of Splenic Amastigotes in Cured Patient and Hamsters .

(2010). Piper betle Linn. a maligned Pan-asiatic plant with an array of pharmacological activities and prospects for drug discovery . Current science.

(2010). Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani .

(2010). Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani .

(2010). Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani .

(2010). 16α-Hydroxycleroda-3,13 (14)Z-dien-15,16-olide from Polyalthia longifolia: a safe and orally active antileishmanial agent .

(2010). Amplified fragment length polymorphism (AFLP) analysis is useful for distinguishing Leishmania species of visceral and cutaneous forms .

(2009). Uptake of Biodegradable Gel-Assisted LBL Nanomatrix by Leishmania donovani-Infected Macrophages .

(2009). Pro-apoptotic effect of the landrace Bangla Mahoba of Piper betle on Leishmania donovani may be due to the high content of eugenol .

(2009). Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis .

(2009). Peganine hydrochloride dihydrate an orally active antileishmanial agent .

(2009). Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis .

(2008). Antileishmanial activity mediated by apoptosis and structure-based target study of peganine hydrochloride dihydrate: an approach for rational drug design .

(2008). Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis .